We searched MEDLINE (January, 2000, to October, 2015) and the Cochrane Library (January, 2000, to October, 2015), using the terms “hyperthyroidism” or “thyrotoxicosis” combined with the terms “Graves' disease”, “toxic adenoma”, “toxic multinodular goiter”, “thyroiditis”, “radioactive iodine therapy”, “antithyroid drugs”, “thyroidectomy”. We also used the reference lists of the selected publications identified by the search strategy and textbooks. Most of the references were selected from
SeminarHyperthyroidism
Introduction
Hyperthyroidism is a pathological disorder in which excess thyroid hormone is synthesised and secreted by the thyroid gland. It is characterised by normal or high thyroid radioactive iodine uptake (thyrotoxicosis with hyperthyroidism or true hyperthyroidism). Thyrotoxicosis without hyperthyroidism is caused by extrathyroidal sources of thyroid hormone or by a release of preformed thyroid hormones into the circulation with a low thyroid radioactive iodine uptake (table 1).1 Hyperthyroidism can be overt or subclinical. Overt hyperthyroidism is characterised by low serum thyroid-stimulating hormone (TSH) concentrations and raised serum concentrations of thyroid hormones: thyroxine (T4), tri-iodothyronine (T3), or both. Subclinical hyperthyroidism is characterised by low serum TSH, but normal serum T4 and T3 concentrations. We do not discuss subclinical hyperthyroidism here, but it was recently reviewed in another Lancet Seminar.2
Section snippets
Epidemiology
Prevalence of hyperthyroidism is 0·8% in Europe,3 and 1·3% in the USA.4 Hyperthyroidism increases with age and is more frequent in women. The prevalence of overt hyperthyroidism is 0·5–0·8% in Europe,3 and 0·5% in the USA.4 Data for ethnic differences are scarce, but hyperthyroidism seems to be slightly more frequent in white people than in other races.3 The incidence of mild hyperthyroidism is also reported to be higher in iodine-deficient areas than in iodine-sufficient areas, and to decrease
Thyrotoxicosis with hyperthyroidism
The most common cause of hyperthyroidism in iodine-sufficient areas is Graves' disease. In Sweden, the annual incidence of Graves' disease is increasing, with 15–30 new cases per 100 000 inhabitants in the 2000s.6, 7 The cause of Graves' disease is thought to be multifactorial, arising from the loss of immunotolerance and the development of autoantibodies that stimulate thyroid follicular cells by binding to the TSH receptor. Several studies have provided some evidence for a genetic
Signs and symptoms due to excess thyroid hormones
Excess thyroid hormone affects many different organ systems (table 2). Commonly reported symptoms are palpitations, fatigue, tremor, anxiety, disturbed sleep, weight loss, heat intolerance, sweating, and polydipsia. Frequent physical findings are tachycardia, tremor of the extremities, and weight loss.21, 22, 23
Signs and symptoms specific to the underlying causes of hyperthyroidism
Signs and symptoms include ophthalmopathy, thyroid dermopathy, and thyroid acropachy in Graves' disease; globus sensation, dysphagia, or orthopnoea due to oesophageal or tracheal
Diagnosis
Serum TSH should be measured first, because it has the highest sensitivity and specificity in the diagnosis of thyroid disorders.42 If low, serum free T4 or free T4 index, and free or total T3 concentrations should be measured to distinguish between subclinical hyperthyroidism (with normal circulating hormones) and overt hyperthyroidism (with increased thyroid hormones). It also identifies disorders with increased thyroid hormone concentrations and normal or only slightly raised TSH
Treatment
The three options for treating patients with hyperthyroidism are antithyroid drugs (ATDs), radioactive iodine ablation, and surgery. All three therapeutic options would be effective in the treatment of patients with Graves' disease, whereas patients with toxic adenoma or toxic multinodular goitre should have either radioactive iodine therapy or surgery, since these patients rarely go into remission.54 In patients with toxic nodular goitre, ATDs are generally used to restore euthyroidism before
Thyroid storm
Thyroid storm is a rare disorder with an incidence of 0·2 per 100 000 person-years in Japan and occurring in 1–5% of patients admitted to hospital for thyrotoxicosis.117, 118, 119 It is an emergency with a high mortality rate of 8–25%.119, 120 The presentation does not depend on serum thyroid hormones concentrations, which are similar to compensated thyrotoxicosis. An apparent trigger can be identified in up to 70% of cases: usually unreliable use or discontinuation of ATD, followed by
Future research
Treatment of hyperthyroidism has not changed greatly in the past several decades. Choices are between long-term therapy, with risk of relapse, or destruction of the thyroid gland with subsequent hypothyroidism. ATDs are a conservative option, but have about a 50% relapse rate; however, thyroidectomy and radioactive iodine treatment are definitive therapies, but with subsequent hypothyroidism needing lifelong therapy with thyroid hormone replacement. Future research should be directed towards a
Search strategy and selection criteria
References (141)
- et al.
Subclinical thyroid disease
Lancet
(2012) - et al.
Stressful life events and Graves' disease
Lancet
(1991) - et al.
Diagnosis and classification of Graves' disease
Autoimmun Rev
(2014) - et al.
Iodine intake as a determinant of thyroid disorders in populations
Best Pract Res Clin Endocrinol Metab
(2010) - et al.
Hyperthyroidism and thyrotoxicosis
Emerg Med Clin North Am
(2014) Thyroid dermopathy and acropachy
Best Pract Res Clin Endocrinol Metab
(2012)- et al.
Mutations in potassium channel Kir2.6 cause susceptibility to thyrotoxic hypokalemic periodic paralysis
Cell
(2010) - et al.
TSH is a negative regulator of skeletal remodeling
Cell
(2003) - et al.
The role of imaging in Graves' disease: a cost-effectiveness analysis
Eur J Radiol
(2008) - et al.
TSH receptor autoantibody immunoassay in patients with Graves' disease: improvement of diagnostic accuracy over different generations of methods. Systematic review and meta-analysis
Autoimmun Rev
(2012)
The incidence and clinical characteristics of symptomatic propylthiouracil-induced hepatic injury in patients with hyperthyroidism: a single-center retrospective study
Am J Gastroenterol
An outbreak of thyrotoxicosis caused by the consumption of bovine thyroid gland in ground beef
N Engl J Med
The incidence and prevalence of thyroid dysfunction in Europe: a meta-analysis
J Clin Endocrinol Metab
Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III)
J Clin Endocrinol Metab
Lower prevalence of mild hyperthyroidism related to a higher iodine intake in the population: prospective study of a mandatory iodization programme
Clin Endocrinol (Oxf)
Incidence rate and clinical features of hyperthyroidism in a long-term iodine sufficient area of Sweden (Gothenburg) 2003-2005
Clin Endocrinol (Oxf)
Incidence of hyperthyroidism in Sweden
Eur J Endocrinol
Role of genetic and non-genetic factors in the etiology of Graves' disease
J Endocrinol Invest
Smoking and thyroid
Clin Endocrinol (Oxf)
The incidence and prevalence of thyroid autoimmunity
Endocrine
Twin studies as a model for exploring the aetiology of autoimmune thyroid disease
Clin Endocrinol (Oxf)
Clinical review 133: progress in understanding the etiology of thyroid autonomy
J Clin Endocrinol Metab
The thyrotropin receptor in thyroid diseases
N Engl J Med
Thyrotropin-induced thyrotoxicosis
Trophoblastic tumors
Clinical features and outcome of subacute thyroiditis in an incidence cohort: Olmsted County, Minnesota, study
J Clin Endocrinol Metab
Incidence rate of symptomatic painless thyroiditis presenting with thyrotoxicosis in Denmark as evaluated by consecutive thyroid scintigraphies
Scand J Clin Lab Invest
Clinical presentation of hyperthyroidism in a large representative sample of outpatients in France: relationships with age, aetiology and hormonal parameters
Clin Endocrinol (Oxf)
Older subjects with hyperthyroidism present with a paucity of symptoms and signs: a large cross-sectional study
J Clin Endocrinol Metab
Extrathyroidal manifestations of Graves' disease: a 2014 update
J Endocrinol Invest
Consensus statement of the European Group on Graves' Orbitopathy (EUGOGO) on management of Graves' orbitopathy
Thyroid
The EUGOGO consensus statement on the management of Graves' orbitopathy: equally applicable to North American clinicians and patients
Thyroid
Clinical assessment of patients with Graves' orbitopathy: the European Group on Graves' Orbitopathy recommendations to generalists, specialists and clinical researchers
Eur J Endocrinol
Dermopathy of Graves' disease (pretibial myxedema): long-term outcome
J Clin Endocrinol Metab
Thyroid acropachy: report of 40 patients treated at a single institution in a 26-year period
J Clin Endocrinol Metab
Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons
N Engl J Med
Effect of hyperthyroidism on the hypercoagulable state and thromboembolic events in patients with atrial fibrillation
Cardiology
Cardiovascular involvement in patients with different causes of hyperthyroidism
Nat Rev Endocrinol
Embolic risk in atrial fibrillation that arises from hyperthyroidism: review of the medical literature
Tex Heart Inst J
Incidence, clinical characteristics and outcome of congestive heart failure as the initial presentation in patients with primary hyperthyroidism
Heart
Subclinical and overt thyroid dysfunction and risk of all-cause mortality and cardiovascular events: a large population study
J Clin Endocrinol Metab
Thyrotoxic periodic paralysis: clinical challenges
J Thyroid Res
The interrelationships between thyroid dysfunction and hypogonadism in men and boys
Thyroid
Thyroid function and human reproductive health
Endocr Rev
Sensitivity, specificity, and cost-effectiveness of the sensitive thyrotropin assay in the diagnosis of thyroid disease in ambulatory patients
Arch Intern Med
Diagnosis and management of thyrotoxicosis
BMJ
Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists
Thyroid
The American Thyroid Association/American Association of Clinical Endocrinologists guidelines for hyperthyroidism and other causes of thyrotoxicosis: a European perspective
Thyroid
A 2011 survey of clinical practice patterns in the management of Graves' disease
J Clin Endocrinol Metab
The American Thyroid Association and American Association of Clinical Endocrinologists hyperthyroidism and other causes of thyrotoxicosis guidelines: viewpoints from Japan and Korea
Thyroid
Cited by (536)
Herbal medicine for Hashimoto's thyroiditis: A systematic review and network meta-analysis
2024, Journal of EthnopharmacologyMyopathies of endocrine origin: A review for physicians
2024, Disease-a-Month